BALCHEM CORP (BCPC) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US0576652004
BALCHEM CORP financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.04 bn USD |
| Gross profit | 370.63 m USD |
| Operating income | 209.33 m USD |
| EBIT | 199.03 m USD |
| Net income | 154.85 m USD |
| Diluted EPS – continuing operations | 4.75 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BALCHEM CORP
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
More stocks
- Glarun Technology Co Ltd (600562.SS)
- JBT MAREL Corp (JBTM)
- Tokyu Fudosan Holdings Corp (3289.T)
- RadNet, Inc. (RDNT)
- Joinn Laboratories(China)Co (603127.SS)
- Logista Integral SA (LOG.MC)
- Mobility Global Inc. (MBGL)
- APT Medical Inc (688617.SS)
- Atlantic Union Bankshares Corp (AUB)
- Shanghai Wanye Enterprises Co Ltd (600641.SS)
- Sumitomo Pharma Co Ltd (4506.T)
- PLAINS GP HOLDINGS LP (PAGP)
Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.